ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether or not ACT01 is effective and tolerable
alone or when used in combination with Comp01, Comp02, Comp03 or Comp04 in patients with
facial and/or scalp keratosis.